Back

PCSK9 inhibitors: the story continues.

27 August 2017 (18:30 - 18:40)
Organised by:
Congress Presentation Part of: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention Endothelial function Open Access ESC Congress 2017

About the speaker

Photo
Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)

2 More presentations in this session

Presentation thumbnail
Challenging the data.
Professor J. Chapman (Paris, FR) Professor P. Sever (London, GB)
Presentation thumbnail
PCSK9 inhibitors: more volumes to come?
Professor J. Chapman (Paris, FR)

Access the full session

Session thumbnail
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention

The Event

Event poster

ESC Congress 2017

27 August 2017 18:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources